US Broker Ratings

Oruka Therapeutics, Inc. (ORKA) Investor Outlook: Analyzing a 71% Potential Upside in Biotechnology

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is drawing significant attention from investors with its promising pipeline in the biotechnology sector. Specializing in the development of monoclonal antibody..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges with Innovative Solutions in Medical Devices

Surmodics, Inc. (NASDAQ: SRDX) stands at the intersection of innovation and challenge within the medical devices sector. With a focus on performance coating technologies for intravascular..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 75.60% Potential Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the design and manufacture of medical instruments and supplies, particularly for treating peripheral..

LifeMD, Inc. (LFMD) Stock Analysis: A Potential Upside of 145% Amidst Growing Telehealth Demand

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, is carving a niche in the rapidly expanding telehealth industry. With a market capitalization of..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Player with Over 100% Upside Potential

Precigen, Inc. (NASDAQ: PGEN) is garnering attention in the biotechnology sector with a striking potential upside of over 100%. As a discovery and clinical-stage biopharmaceutical company,..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Promising 119% Potential Upside in the Biotech Sector

Prothena Corporation plc (NASDAQ: PRTA), an Irish biotechnology firm, has captured the attention of investors with its robust product pipeline targeting diseases caused by protein dysregulation...

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unveiling a 276% Potential Upside in the Biotech Arena

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its potential upside of 276.13%. This..

Auna SA (AUNA) Stock Analysis: Exploring a 90.63% Potential Upside in Healthcare

Investors seeking opportunities in the healthcare sector might find Auna SA (AUNA) an intriguing prospect, as its current market dynamics present a significant potential upside. Operating..

OrthoPediatrics Corp. (KIDS) Stock Analysis: A Promising Growth in Pediatric Orthopedics with 28.94% Potential Upside

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector, is carving a niche in the medical devices industry by focusing on pediatric orthopedics. Headquartered..

Semler Scientific, Inc. (SMLR) Stock Analysis: A Medical Device Innovator with 223% Potential Upside

Semler Scientific, Inc. (NASDAQ: SMLR), a player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors with its remarkable potential upside..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Navigating the Diagnostics Frontier with a Promising 12.88% Upside

Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $1.19 billion,..

Organogenesis Holdings Inc. (ORGO) Stock Report: Analyzing a 114% Potential Upside in Regenerative Medicine

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, is drawing attention from investors with its significant potential upside of 114.11%. Specializing..

Septerna, Inc. (SEPN) Stock Report: Exploring a 21% Potential Upside Amidst Robust Growth Prospects

Septerna, Inc. (SEPN), a dynamic player in the biotechnology sector, is gaining attention from investors seeking high-growth opportunities in the healthcare industry. Founded in 2019 and..

Celcuity Inc. (CELC): Investment Insights on a Biotech Trailblazer with Strong Buy Ratings

For investors with a keen eye on the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) presents an intriguing opportunity. With a market capitalization of $4.87 billion, this..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring an 82% Potential Upside in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is gaining attention in the biotech sector, not only because of its innovative approach to tackling cancer resistance mechanisms but also..

Verastem, Inc. (VSTM): Investor Outlook on Biotech’s 144% Potential Upside

Verastem, Inc. (NASDAQ: VSTM) has emerged as a biotech company capturing attention with its promising pipeline and significant upside potential. With its current market capitalization of..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Potential Upside with a Focused Healthcare Strategy

Enhabit, Inc. (NASDAQ: EHAB), a significant player in the U.S. healthcare sector, offers a compelling investment opportunity for those looking to enter the medical care facilities..

AtaiBeckley Inc. (ATAI): Biotechnology Innovator with a 234% Potential Upside

AtaiBeckley Inc. (NASDAQ: ATAI), a prominent player in the biotechnology sector, is making significant strides in developing innovative mental health treatments. With a market capitalization of..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Exploring 49.57% Potential Upside

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands out in the healthcare sector as a dynamic player within the specialty and generic drug manufacturing industry. With a market..

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a 45% Potential Upside in the Biotech Sector

MBX Biosciences, Inc. (MBX), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector with its focused approach on precision peptide therapies designed to address..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds